ProShares Ultra NASDAQ Biotechnology
21 hedge funds and large institutions have $6.5M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 5 closing their positions.
Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
5
Closed
5
Calls
$752K
Puts
$465K
Net Calls
+$287K
Net Calls Change
+$495K
Top Buyers
1 |
1
IMC Chicago
Chicago,
Illinois
|
$1.46M |
2 |
WWM
2
Westwood Wealth Management
Los Angeles,
California
|
$893K |
3 |
3
Jane Street
New York
|
$306K |
4 |
TC
4
Truvestments Capital
Sarasota,
Florida
|
$7.97K |
5 |
5
Morgan Stanley
New York
|
$51.5K |